Childhood pemphigus vulgaris is a challenging diagnosis
Gastão Tenório Lins Filho; Nathalia Lages Sarmento Barbosa; Eulina Maria Vieira de Abreu; Klinger Vagner Teixeira da Costa; Kelly Chrystine Barbosa Meneses; Rodrigo Neves Silva; Sonia Maria Soares Ferreira
Abstract
Keywords
References
1 Kincaid L, Weinstein M. Rituximab therapy for childhood pemphigus vulgaris. Pediatr Dermatol. 2016;33(2):e61-4.
2 Surya V, Kumar P, Gupta S, Urs AB. Childhood pemphigus vulgaris: report of two cases with emphasis on diagnostic approach. Contemp Clin Dent. 2018;9(6, Suppl 2):S373-6.
3 Gürcan HM, Mabrouk D, Razzaque Ahmed A. Management of pemphigus in pediatric patients. Minerva Pediatr. 2011;63(4):279-91. PMid:21909064.
4 Porro AM, Seque CA, Ferreira MCC, Enokihara MMSS. Pemphigus vulgaris. An Bras Dermatol. 2019;94(3):264-78.
5 Gonul M, Keseroglu HO. Pediatric Phemphigus. Clin Pediatr Dermatol. 2015;1(1):1-3.
6 Fuertes I, Guilabert A, Mascaró JM Jr, Iranzo P. Rituximab in childhood pemphigus vulgaris: a long-term follow-up case and review of the literature. Dermatology. 2010;221(1):13-6.
7 Vinay K, Kanwar AJ, Sawatkar GU, Dogra S, Ishii N, Hashimoto T. Successful use of rituximab in the treatment of childhood and juvenile pemphigus. J Am Acad Dermatol. 2014;71(4):669-75.
8 Broshtilova V, Vassileva S. A case of pediatric pemphigus treated with rituximab: our experience. Asian J Res Dermatology Science. 2019;2(1):1-6.
9 Casuriaga Lamboglia AL, Minut Gubitosi A, Guebenlián Bakerdjian C, Giachetto Larraz G. Pemphigus vulgaris in pediatrics: a case report. Rev Chil Pediatr. 2018;89(5):650-4. PMid:30571809.
10 Bajpai M, Pardhe N, Chandolia B. Oral pemphigus vulgaris in a pediatric patient. J Ayub Med Coll Abbottabad. 2016;28(3):636. PMid:28712257.
11 Suliman NM, Åstrøm AN, Ali RW, Salman H, Johannessen AC. Clinical and histological characterization of oral pemphigus lesions in patients with skin diseases: a cross sectional study from Sudan. BMC Oral Health. 2013;13(1):66.
12 Aoki V, Sousa JX Jr, Fukumori LM, Périgo AM, Freitas EL, Oliveira ZN. Direct and indirect immunofluorescence. An Bras Dermatol. 2010;85(4):490-500.
13 Ariyawardana A, Tilakaratne WM, Dissanayake M, et al. Oral pemphigus vulgaris in children and adolescents: a review of the literature and a case report. Int J Paediatr Dent. 2005;15(4):287-93.
14 Martinez AB, Corcuera MM, Ilundain CB, Gómez GE. Oral manifestations of pemphigus vulgaris: clinical presentation, differential diagnosis and management. J Clin Exp Dermatol Res. 2010;1(3):1-4.
15 Wozel G, Blasum C. Dapsone in dermatology and beyond. Arch Dermatol Res. 2014;306(2):103-24.
16 Quaresma MV, Bernardes F Fo, Hezel J, Peretti MC, Kac BK, Azulay-Abulafia L.. Dapsone in the treatment of pemphigus vulgaris: adverse effects and its importance as a corticosteroid sparing agente. An Bras Dermatol. 2015;90(3, Suppl 1):S51-4.
17 Cervera-Castillo H, Torres-Caballero V, Martínez-García E, Pizaña-Serna M, Blanco-Favela FA. Granulomatosis de Wegener: estado de portador de Staphylococcus aureus y terapéutica combinada. Rev Med Inst Mex Seguro Soc. 2006;44(3):249-55. PMid:16870120.
18 Bilgic‐Temel A, Özgen Z, Harman M, Kapıcıoğlu Y, Uzun S. Rituximab therapy in pediatric pemphigus patients: a retrospective analysis of five Turkish patients and review of the literature. Pediatr Dermatol. 2019;36(5):646-50.
19 Buch JY, Raval RC. Successful treatment of refractory childhood vesiculobullous disorders with rituximab: a study of five cases. Indian J Paediatr Dermatol. 2016;17(2):104-7.
Submitted date:
11/04/2020
Accepted date:
02/01/2021
Publication date:
04/30/2021
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email